New Risk • May 11
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 40% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€21.6m market cap, or US$25.4m). Buy Or Sell Opportunity • Apr 24
Now 24% undervalued Over the last 90 days, the stock has risen 3.2% to €1.04. The fair value is estimated to be €1.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%. Buy Or Sell Opportunity • Apr 08
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 19% to €0.99. The fair value is estimated to be €1.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%. Buy Or Sell Opportunity • Mar 23
Now 25% undervalued after recent price drop Over the last 90 days, the stock has fallen 32% to €0.96. The fair value is estimated to be €1.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%. Announcement • Oct 22
Egide S.A. Provides Earnings Guidance for the Second Half of 2025 Egide S.A. provided earnings guidance for the second half of 2025. For the second half, the Group expects revenue to grow in the second half of 2025 (H2 2025), driven by: Egide SA: continued commercial recovery as experienced in H1, with an expansion of the customer base in the European and North American markets; Egide USA: continued growth momentum in high value-added segments; Santier: active search for new opportunities to offset the end of major contracts, but weak activity is expected to persist in H2. Announcement • Aug 06
Egide S.A., Annual General Meeting, Sep 10, 2025 Egide S.A., Annual General Meeting, Sep 10, 2025. Location: site industriel du sactar, bollene France Announcement • Jul 03
Egide S.A. Announces CEO Changes After four years at Egide S.A. announced David HIEN will leave the EGIDE Group and his position as CEO on July 31, 2025. The Board of Directors, meeting on July 1st, 2025, under the chairmanship of Philippe BENSUSSAN, announced the appointment of Ignace DUPON as Group CEO, effective August 1, 2025. This appointment is part of an operational and strategic continuity, with Ignace DUPON having held key positions within the Group for more than ten years and currently leading US operations as General Manager of Egide USA since 2023 and Santier since 2024. With a civil engineering degree in electronics and management from the University of Leuven (KUL), Ignace DUPON is known for his leadership, strategic vision, and ability to grow businesses in complex international markets. International executive with over 30 years' experience in the high-tech and industrial sectors, he has held key positions within the Egide Group since 2014: Sales Director for Europe and Asia, then in the U.S. as Purchasing Director and now as GM of the Cambridge and San Diego (MD) sites. At EGIDE, he has led major strategic transformations including a return to profitability, client portfolio diversification, industrial restructuring, and the development of strategic accounts. Prior to Egide, he held senior purchasing, commercial and business development roles at Keopsys, Highwave Optical Technologies, and Alcatel Optronics, where he built international teams and negotiated industrial partnerships. Buy Or Sell Opportunity • Jun 27
Now 25% undervalued after recent price drop Over the last 90 days, the stock has fallen 26% to €0.52. The fair value is estimated to be €0.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Announcement • Jun 17
Egide S.A. to Report Fiscal Year 2024 Final Results on Jun 30, 2025 Egide S.A. announced that they will report fiscal year 2024 final results at 5:40 PM, Central European Standard Time on Jun 30, 2025 Reported Earnings • May 04
Full year 2024 earnings released Full year 2024 results: Revenue: €30.0m (down 18% from FY 2023). Net loss: €2.48m (loss narrowed 21% from FY 2023). Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Electronic industry in the United Kingdom. New Risk • Apr 07
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €8.12m (US$8.87m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Earnings have declined by 21% per year over the past 5 years. Market cap is less than US$10m (€8.12m market cap, or US$8.87m). Minor Risk Shareholders have been diluted in the past year (21% increase in shares outstanding). New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (€8.43m market cap, or US$8.67m). Announcement • Nov 12
Egide S.A. has filed a Follow-on Equity Offering in the amount of €1.695104 million. Egide S.A. has filed a Follow-on Equity Offering in the amount of €1.695104 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 2,607,853
Price\Range: €0.65
Transaction Features: Subsequent Direct Listing Announcement • Jun 19
Egide S.A. to Report Fiscal Year 2023 Results on Jul 15, 2024 Egide S.A. announced that they will report fiscal year 2023 results at 12:00 PM, Central European Standard Time on Jul 15, 2024 Announcement • Nov 23
Egide S.A. has filed a Follow-on Equity Offering. Egide S.A. has filed a Follow-on Equity Offering.
Security Name: Shares
Security Type: Common Stock
Transaction Features: Rights Offering Announcement • Sep 07
Egide S.A. has completed a Follow-on Equity Offering in the amount of €1.921561 million. Egide S.A. has completed a Follow-on Equity Offering in the amount of €1.921561 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 2,956,248
Price\Range: €0.65
Transaction Features: Rights Offering Announcement • Sep 06
Egide S.A. to Report First Half, 2023 Results on Oct 26, 2023 Egide S.A. announced that they will report first half, 2023 results on Oct 26, 2023 Board Change • Aug 18
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Jul 22
Egide S.A. Provides Sales Guidance for the Second Half of 2023 Egide S.A. provided sales guidance for the second half of 2023. Driven by strong sales momentum across all products in first half of 2023, the company intends to maintain a similar level of revenue in the second half of 2023. New Risk • Jul 14
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.2% Last year net profit margin: 4.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Shares are highly illiquid. High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (€6.58m market cap, or US$7.39m). Minor Risk Profit margins are more than 30% lower than last year (2.2% net profit margin). Board Change • Jul 14
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • May 05
An unknown buyer signed a non-binding letter of intent to acquire Egide USA, Inc. from Egide S.A. (ENXTPA:ALGID). An unknown buyer signed a non-binding letter of intent to acquire Egide USA, Inc. from Egide S.A. (ENXTPA:ALGID) on May 3, 2023. Board Change • Apr 15
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Mar 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 04
Full year 2021 earnings released Full year 2021 results: Revenue: €32.5m (up 8.4% from FY 2020). Net income: €50.0k (down 95% from FY 2020). Profit margin: 0.2% (down from 3.3% in FY 2020). Over the next year, revenue is forecast to grow 12%, compared to a 8.2% growth forecast for the industry in the United Kingdom. Board Change • Mar 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 
